Manufacturer
NOVARTIS FARMACEUTICA S.A.
Contents
Rivastigmine hydrogen tartrate
Indication
Alzheimer's dementia, Dementia associated with Parkinson's disease.
Instruction
Should be taken with food.
Drug interaction
Additive effect with succinylcholine-type muscle relaxants during anaesthesia; cholinometric substances (e.g. oxybutynin, tolterodine). Additive effect and increased risk of bradycardia with beta-blockers (e.g. atenolol). Increased risk of torsade de pointes with phenothiazines (e.g. chlorpromazine); benzamides (e.g. sulpiride, sultopride), pimozide, cisapride.
Malaysia
